These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 16434898)

  • 21. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
    Morrison JC; Blanco LZ; Vang R; Ronnett BM
    Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
    Carlson JW; Miron A; Jarboe EA; Parast MM; Hirsch MS; Lee Y; Muto MG; Kindelberger D; Crum CP
    J Clin Oncol; 2008 Sep; 26(25):4160-5. PubMed ID: 18757330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
    Ayres C; Ratnayake G; McNally O; Quinn M
    Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.
    Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M
    Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
    Poon C; Hyde S; Grant P; Newman M; Ireland Jenkin K
    Int J Gynecol Cancer; 2016 Oct; 26(8):1415-20. PubMed ID: 27488216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
    Crum CP; Drapkin R; Miron A; Ince TA; Muto M; Kindelberger DW; Lee Y
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):3-9. PubMed ID: 17218844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
    Callahan MJ; Crum CP; Medeiros F; Kindelberger DW; Elvin JA; Garber JE; Feltmate CM; Berkowitz RS; Muto MG
    J Clin Oncol; 2007 Sep; 25(25):3985-90. PubMed ID: 17761984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
    Folkins AK; Jarboe EA; Saleemuddin A; Lee Y; Callahan MJ; Drapkin R; Garber JE; Muto MG; Tworoger S; Crum CP
    Gynecol Oncol; 2008 May; 109(2):168-73. PubMed ID: 18342932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
    Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
    Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serous carcinogenesis in the fallopian tube: a descriptive classification.
    Jarboe E; Folkins A; Nucci MR; Kindelberger D; Drapkin R; Miron A; Lee Y; Crum CP
    Int J Gynecol Pathol; 2008 Jan; 27(1):1-9. PubMed ID: 18156967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
    Cass I; Walts AE; Barbuto D; Lester J; Karlan B
    Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas.
    Dowson CB; Stewart C; O'Sullivan S; Pachter N; Schofield L; Cohen PA
    Int J Gynecol Cancer; 2020 Jan; 30(1):94-99. PubMed ID: 31699802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.
    Piek JM; Torrenga B; Hermsen B; Verheijen RH; Zweemer RP; Gille JJ; Kenemans P; van Diest PJ; Menko FH
    Fam Cancer; 2003; 2(2):73-8. PubMed ID: 14574155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
    Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
    Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
    Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
    Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.